Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 3333.76 | 651 / 653 | 99% | 74.98 | 601 / 605 |
lung | 100% | 7678.80 | 578 / 578 | 98% | 59.18 | 1132 / 1155 |
breast | 100% | 4093.49 | 459 / 459 | 97% | 36.09 | 1086 / 1118 |
uterus | 100% | 4611.34 | 170 / 170 | 97% | 53.63 | 445 / 459 |
skin | 98% | 2789.18 | 1768 / 1809 | 99% | 51.49 | 468 / 472 |
intestine | 99% | 2520.67 | 958 / 966 | 97% | 42.80 | 512 / 527 |
ovary | 100% | 3717.26 | 180 / 180 | 94% | 48.97 | 405 / 430 |
esophagus | 100% | 3292.01 | 1443 / 1445 | 94% | 27.16 | 172 / 183 |
bladder | 100% | 3255.62 | 21 / 21 | 90% | 35.04 | 453 / 504 |
prostate | 100% | 4116.42 | 245 / 245 | 87% | 23.17 | 435 / 502 |
kidney | 99% | 2885.81 | 88 / 89 | 82% | 36.04 | 735 / 901 |
stomach | 85% | 1574.64 | 305 / 359 | 95% | 30.91 | 273 / 286 |
adrenal gland | 97% | 1543.92 | 251 / 258 | 54% | 11.84 | 124 / 230 |
pancreas | 28% | 289.26 | 92 / 328 | 97% | 59.85 | 173 / 178 |
adipose | 100% | 5321.67 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5742.33 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 7024.47 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 3442.56 | 860 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 79.96 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 98% | 75.32 | 78 / 80 |
lymph node | 0% | 0 | 0 / 0 | 93% | 33.04 | 27 / 29 |
peripheral blood | 91% | 2713.21 | 844 / 929 | 0% | 0 | 0 / 0 |
brain | 26% | 257.50 | 692 / 2642 | 63% | 12.39 | 447 / 705 |
liver | 28% | 265.78 | 64 / 226 | 34% | 6.90 | 138 / 406 |
muscle | 37% | 416.44 | 294 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0002221 | Biological process | pattern recognition receptor signaling pathway |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0060340 | Biological process | positive regulation of type I interferon-mediated signaling pathway |
GO_0000045 | Biological process | autophagosome assembly |
GO_0045087 | Biological process | innate immune response |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0051607 | Biological process | defense response to virus |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0070972 | Biological process | protein localization to endoplasmic reticulum |
GO_0035458 | Biological process | cellular response to interferon-beta |
GO_0051259 | Biological process | protein complex oligomerization |
GO_0140896 | Biological process | cGAS/STING signaling pathway |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_0002218 | Biological process | activation of innate immune response |
GO_0061709 | Biological process | reticulophagy |
GO_0071360 | Biological process | cellular response to exogenous dsRNA |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0071407 | Biological process | cellular response to organic cyclic compound |
GO_0002753 | Biological process | cytoplasmic pattern recognition receptor signaling pathway |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005777 | Cellular component | peroxisome |
GO_1902554 | Cellular component | serine/threonine protein kinase complex |
GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_1990231 | Cellular component | STING complex |
GO_0005829 | Cellular component | cytosol |
GO_0005776 | Cellular component | autophagosome |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005768 | Cellular component | endosome |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0015252 | Molecular function | proton channel activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0061507 | Molecular function | 2',3'-cyclic GMP-AMP binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0035438 | Molecular function | cyclic-di-GMP binding |
Gene name | STING1 |
Protein name | Stimulator of interferon genes protein (hSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (hMITA) (Transmembrane protein 173) Stimulator of interferon genes protein STING isoform 1 Stimulator of interferon response cGAMP interactor 1 STING isoform 2 STING isoform 3 |
Synonyms | ERIS TMEM173 STING MITA |
Description | FUNCTION: Facilitator of innate immune signaling that acts as a sensor of cytosolic DNA from bacteria and viruses and promotes the production of type I interferon (IFN-alpha and IFN-beta) . Innate immune response is triggered in response to non-CpG double-stranded DNA from viruses and bacteria delivered to the cytoplasm . Acts by binding cyclic dinucleotides: recognizes and binds cyclic di-GMP (c-di-GMP), a second messenger produced by bacteria, cyclic UMP-AMP (2',3'-cUAMP), and cyclic GMP-AMP (cGAMP), a messenger produced by CGAS in response to DNA virus in the cytosol . Upon binding to c-di-GMP, cUAMP or cGAMP, STING1 oligomerizes, translocates from the endoplasmic reticulum and is phosphorylated by TBK1 on the pLxIS motif, leading to recruitment and subsequent activation of the transcription factor IRF3 to induce expression of type I interferon and exert a potent anti-viral state . Exhibits 2',3' phosphodiester linkage-specific ligand recognition: can bind both 2'-3' linked cGAMP (2'-3'-cGAMP) and 3'-3' linked cGAMP but is preferentially activated by 2'-3' linked cGAMP . The preference for 2'-3'-cGAMP, compared to other linkage isomers is probably due to the ligand itself, whichs adopts an organized free-ligand conformation that resembles the STING1-bound conformation and pays low energy costs in changing into the active conformation . In addition to promote the production of type I interferons, plays a direct role in autophagy . Following cGAMP-binding, STING1 buds from the endoplasmic reticulum into COPII vesicles, which then form the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) . The ERGIC serves as the membrane source for WIPI2 recruitment and LC3 lipidation, leading to formation of autophagosomes that target cytosolic DNA or DNA viruses for degradation by the lysosome . Promotes autophagy by acting as a proton channel that directs proton efflux from the Golgi to facilitate MAP1LC3B/LC3B lipidation . The autophagy- and interferon-inducing activities can be uncoupled and autophagy induction is independent of TBK1 phosphorylation . Autophagy is also triggered upon infection by bacteria: following c-di-GMP-binding, which is produced by live Gram-positive bacteria, promotes reticulophagy (By similarity). May be involved in translocon function, the translocon possibly being able to influence the induction of type I interferons . May be involved in transduction of apoptotic signals via its association with the major histocompatibility complex class II (MHC-II) (By similarity). .; FUNCTION: (Microbial infection) Antiviral activity is antagonized by oncoproteins, such as papillomavirus (HPV) protein E7 and adenovirus early E1A protein . Such oncoproteins prevent the ability to sense cytosolic DNA . . |
Accessions | ENST00000672096.1 A0A3S9KRD0 ENST00000672102.1 ENST00000652271.1 J3QTB1 ENST00000651699.1 ENST00000652543.1 Q86WV6 ENST00000672865.1 A0A494C1N5 ENST00000651565.1 ENST00000652110.1 ENST00000330794.9 A0A3S9KRB7 A0A3S9KRB2 A0A494C0W5 ENST00000650883.1 A0A494C0T1 |